Logo

Cabinet invests nearly €800 million in six innovative projects

Six innovative projects will receive €780.9 million from the National Growth Fund.

Published on July 7, 2025

funding

Team IO+ selects and features the most important news stories on innovation and technology, carefully curated by our editors.

Six projects will receive a definitive €780.9 million from the National Growth Fund (NGF). This was decided by the Council of Ministers on the proposal of Minister Karremans of Economic Affairs and Minister Heinen of Finance. The contribution will go, for example, to a project that accelerates and improves the development of new cancer therapies. The government is also investing in the development of photonic chips, which can be used for faster diagnosis of diseases, safe self-driving vehicles, and more efficient food production.

The projects that will now receive a definitive contribution from the National Growth Fund come from the second and third rounds of the fund. At the request of the cabinet, the projects have refined their plans and submitted additional information in order to be eligible for a definitive grant.

Developing new cancer therapies

Oncode Accelerator has been awarded €123 million for a project that accelerates and improves the development of new cancer therapies.

Developing photonic chips

PhotonDelta has been awarded €100.8 million for the development of photonic chips.

Bringing biotech knowledge to the market

Biotech Booster has been awarded €196.4 million to bring biotechnological knowledge to market more quickly in the Netherlands.

Developing and embedding training courses in healthcare

DUTCH has been awarded €34 million to develop and embed training courses in healthcare practice.

Developing ICT infrastructure in education

Npuls has been awarded €244.7 million for developing joint ICT infrastructure and knowledge infrastructure for education.

Improving the quality of education

Ontwikkelkracht has been awarded €82 million for strengthening the quality of primary and secondary education through practice-oriented research, collaboration, and knowledge sharing.

Occam Dx

National Growth Fund invests €1.4 million in Twente biotech projects

Diagnosing life-threatening diseases and innovative immunotherapy: these biotech projects get a boost.